Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 06 Oct 2017 Status changed from not yet recruiting to recruiting.
- 15 Aug 2017 Planned initiation date changed from 1 May 2017 to 1 Sep 2017.
- 20 Apr 2017 New trial record